Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice

Identifieur interne : 001137 ( Main/Merge ); précédent : 001136; suivant : 001138

PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice

Auteurs : Xunlong Shi [République populaire de Chine] ; Zhihui Shi [République populaire de Chine] ; Hai Huang [République populaire de Chine] ; Hongguang Zhu [République populaire de Chine] ; Haiyan Zhu [République populaire de Chine] ; Dianwen Ju [République populaire de Chine] ; Pei Zhou [République populaire de Chine]

Source :

RBID : ISTEX:621B71884910C782C78D561E2632C03AA44CC088

English descriptors

Abstract

Abstract: Therapeutic recombinant human catalase (rhCAT) can quench infection-induced reactive oxygen species (ROS), thereby alleviating the associated tissue damage. Although the intranasal route is efficient to deliver native rhCAT to the lung, the therapeutic effect is limited by rapid elimination from the blood. In this study, we modified rhCAT with the active polymer, polyethylene glycol monomethyl ether (PEG)-5000, and analyzed the pharmacokinetics of PEGylated rhCAT in mice. The high tetra-PEGylation ratio was about 60 %, and PEGylation prolonged the half-life of rhCAT in serum (75 vs. 13.5 min for native rhCAT). The protective effects of PEG-rhCAT were investigated in a mouse model of influenza virus A (H1N1)-associated pneumonia. PEG-rhCAT was more effectively delivered than native rhCAT and was associated with higher survival ratio, less extensive lung injuries, reduced ROS levels, and lower viral replication. Collectively, these findings indicate that PEGylation can enhance the therapeutic efficacy of native rhCAT and suggest that PEGylated rhCAT may represent a novel complement therapy for H1N1 influenza-induced pneumonia.

Url:
DOI: 10.1007/s00253-013-4775-3

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:621B71884910C782C78D561E2632C03AA44CC088

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice</title>
<author>
<name sortKey="Shi, Xunlong" sort="Shi, Xunlong" uniqKey="Shi X" first="Xunlong" last="Shi">Xunlong Shi</name>
</author>
<author>
<name sortKey="Shi, Zhihui" sort="Shi, Zhihui" uniqKey="Shi Z" first="Zhihui" last="Shi">Zhihui Shi</name>
</author>
<author>
<name sortKey="Huang, Hai" sort="Huang, Hai" uniqKey="Huang H" first="Hai" last="Huang">Hai Huang</name>
</author>
<author>
<name sortKey="Zhu, Hongguang" sort="Zhu, Hongguang" uniqKey="Zhu H" first="Hongguang" last="Zhu">Hongguang Zhu</name>
</author>
<author>
<name sortKey="Zhu, Haiyan" sort="Zhu, Haiyan" uniqKey="Zhu H" first="Haiyan" last="Zhu">Haiyan Zhu</name>
</author>
<author>
<name sortKey="Ju, Dianwen" sort="Ju, Dianwen" uniqKey="Ju D" first="Dianwen" last="Ju">Dianwen Ju</name>
</author>
<author>
<name sortKey="Zhou, Pei" sort="Zhou, Pei" uniqKey="Zhou P" first="Pei" last="Zhou">Pei Zhou</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:621B71884910C782C78D561E2632C03AA44CC088</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1007/s00253-013-4775-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-194FWCL7-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000491</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000491</idno>
<idno type="wicri:Area/Istex/Curation">000491</idno>
<idno type="wicri:Area/Istex/Checkpoint">000287</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000287</idno>
<idno type="wicri:doubleKey">0175-7598:2013:Shi X:pegylated:human:catalase</idno>
<idno type="wicri:Area/Main/Merge">001137</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice</title>
<author>
<name sortKey="Shi, Xunlong" sort="Shi, Xunlong" uniqKey="Shi X" first="Xunlong" last="Shi">Xunlong Shi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shi, Zhihui" sort="Shi, Zhihui" uniqKey="Shi Z" first="Zhihui" last="Shi">Zhihui Shi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huang, Hai" sort="Huang, Hai" uniqKey="Huang H" first="Hai" last="Huang">Hai Huang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Hongguang" sort="Zhu, Hongguang" uniqKey="Zhu H" first="Hongguang" last="Zhu">Hongguang Zhu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Haiyan" sort="Zhu, Haiyan" uniqKey="Zhu H" first="Haiyan" last="Zhu">Haiyan Zhu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ju, Dianwen" sort="Ju, Dianwen" uniqKey="Ju D" first="Dianwen" last="Ju">Dianwen Ju</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Pei" sort="Zhou, Pei" uniqKey="Zhou P" first="Pei" last="Zhou">Pei Zhou</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Drug Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">République populaire de Chine</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Applied Microbiology and Biotechnology</title>
<title level="j" type="abbrev">Appl Microbiol Biotechnol</title>
<idno type="ISSN">0175-7598</idno>
<idno type="eISSN">1432-0614</idno>
<imprint>
<publisher>Springer Berlin Heidelberg</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2013-12-01">2013-12-01</date>
<biblScope unit="volume">97</biblScope>
<biblScope unit="issue">23</biblScope>
<biblScope unit="page" from="10025">10025</biblScope>
<biblScope unit="page" to="10033">10033</biblScope>
</imprint>
<idno type="ISSN">0175-7598</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0175-7598</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Catalase</term>
<term>Influenza</term>
<term>Oxidative stress</term>
<term>PEGylation</term>
<term>Pneumonia</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Therapeutic recombinant human catalase (rhCAT) can quench infection-induced reactive oxygen species (ROS), thereby alleviating the associated tissue damage. Although the intranasal route is efficient to deliver native rhCAT to the lung, the therapeutic effect is limited by rapid elimination from the blood. In this study, we modified rhCAT with the active polymer, polyethylene glycol monomethyl ether (PEG)-5000, and analyzed the pharmacokinetics of PEGylated rhCAT in mice. The high tetra-PEGylation ratio was about 60 %, and PEGylation prolonged the half-life of rhCAT in serum (75 vs. 13.5 min for native rhCAT). The protective effects of PEG-rhCAT were investigated in a mouse model of influenza virus A (H1N1)-associated pneumonia. PEG-rhCAT was more effectively delivered than native rhCAT and was associated with higher survival ratio, less extensive lung injuries, reduced ROS levels, and lower viral replication. Collectively, these findings indicate that PEGylation can enhance the therapeutic efficacy of native rhCAT and suggest that PEGylated rhCAT may represent a novel complement therapy for H1N1 influenza-induced pneumonia.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001137 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001137 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:621B71884910C782C78D561E2632C03AA44CC088
   |texte=   PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021